The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

CPD The management of familial hypercholesterolaemia

Publication date: Wednesday, 14 May 2014
Contributor(s): Dr Mary Seed, Professor Gilbert R Thompson

Homozygous familial hypercholesterolaemia (FH) is a rare disorder with a very high risk of premature cardiac death that must be diagnosed and treated from childhood onwards, usually with lifelong lipoprotein apheresis. Heterozygous FH is much commoner, with a high risk of cardiovascular disease in adults that can be prevented by early diagnosis and statin therapy.

HUK_logo_smallcmyk_HR
HEART UK - The Cholesterol Charity - has provided editorial support and review of this sponsored FH series.



SANOFI_Logo_Horizontal_2011_4colors
This article was made possible by an unrestricted educational grant by Sanofi, who had no control over content.

Sponsorship information:
This article was made possible by an unrestricted educational grant by Sanofi, who had no control over content.
Category: Editorial
Edition: Volume 7 Number 2 Apr-May-Jun 2014
Print edition page(s): 89
Contributor(s): Dr Mary Seed, Professor Gilbert R Thompson

Article search and filter